Umfang:
1 electronic resource (348 pages)
ISBN:
9783039217076
Inhalt:
Tissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, and now accumulating evidence suggests that fibrotic lesions enhance the risk of cancer in several organs such as liver, lungs, and breast. Disruption of an organ parenchymal cells and of its normal structural scaffold during tissue fibrogenesis appears to induce loss of cell polarity, promoting uncontrolled cell proliferation that may eventually lead to cancer development. Many cellular and molecular abnormalities including aberrant expression of microRNAs, genetic and epigenetic alterations, evasion or delayed apoptosis, unregulated intracellular signal pathways, and dysregulation or defective intercellular communications have been proposed to explain this link between fibrogenesis and carcinogenesis. However, the precise mechanisms of this fibrosis-to-cancer transition remain unclear. This book presents a collection of reviews and original articles summarizing recent advances in understanding the molecular mechanisms of cancer development in fibrotic organs
Anmerkung:
This is a reprint of articles from the special issue published online in the open access journal International Journal of Molecular Sciences
Weitere Ausg.:
Erscheint auch als Druck-Ausgabe, Paperback ISBN 978-3-03921-706-9
Sprache:
Englisch
DOI:
10.3390/books978-3-03921-707-6
URL:
Volltext
(kostenfrei)
URL:
https://mdpi.com/books/pdfview/book/1794
Bookmarklink
